MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    ODM-104 and optimized carbidopa dose show beneficial effect on levodopa PK in healthy subjects

    J. Tuunainen, J. Ellmén, M. Vahteristo, A. Holopainen, D. Strugala (Espoo, Finland)

    Objective: To study the dose effects of a novel catechol-O-methyl transferase (COMT) inhibitor ODM-104 and the aromatic L-amino acid decarboxylase (AADC) inhibitor carbidopa on levodopa…
  • 2018 International Congress

    Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson’s Disease

    J. Boyd, C. Zadikoff, M. Siddiqui, J. Benesh, J. Zamudio, W. Robieson, P. Kukreja (Burlington, VT, USA)

    Objective: Evaluate efficacy/safety of levodopa-carbidopa intestinal gel (LCIG) daytime monotherapy (with/without nighttime oral carbidopa/levodopa) vs polytherapy (LCIG with >1 adjunctive therapy) in advanced Parkinson’s disease…
  • 2018 International Congress

    Levodopa Induced Orthostatic Hypotension in Parkinson’s Disease: A Single-Dose Response Study

    K. Thiankhaw, S. Tanprawate, A. Soontornpun, A. Nudsasarn, S. Chankrachang (Chiang Mai, Thailand)

    Objective: To determine the effect and risk factors of a single dose levodopa induced OH in PD Background: Levodopa (LD) is widely recognised as the…
  • 2018 International Congress

    The outcome of directional subthalamic deep brain stimulation in advanced Parkinson’s disease

    M. Koivu, F. Scheperjans, J. Eerola-Rautio, J. Resendiz-Nieves, J. Marjamaa, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

    Objective: To assess the outcome of patients with advanced Parkinson’s disease (PD) treated with directional DBS. Background: Subthalamic deep brain stimulation (STN-DBS) has proved to…
  • 2018 International Congress

    Dysphagia predicts poor outcome in late-stage Parkinson’s disease

    M. Fabbri, D. Abreu, L. Guedes, M. Rosa, A. Antonini, M. Zibetti, L. Lopiano, J. Fereira, M. Coelho (Lisbon, Portugal)

    Objective: to evaluate the clinical progression and prognostic factors of a late-stage PD (LSPD) population. Background: Parkinson’s disease (PD) disability milestones emerge in an exponential…
  • 2018 International Congress

    Movement Disorders as Postinfectious Neurologic Syndromes

    H. Mori (Kurashiki, Okayama, Japan)

    Objective: We shows the three patients which some neurologists diagnosed psychological disorders at first. Their movement disorders are due to postinfectious neurologic syndromes (Epstein-Barr virus…
  • 2018 International Congress

    Movement disorders in mitochondrial disease: Radio clinical correlation in pediatric patients

    R. Zouari, M. Naifar, F. Kamoun, S. Ben Nsir, R. Ben Jemaa, W. Bouchaala, F. Ayadi, C. Triki (Sfax, Tunisia)

    Objective: Investigate the clinical features of movement disorders (MD), as well as brain imaging findings, in order to identify a radio-clinical correlation in mitochondrial diseases…
  • 2018 International Congress

    Clinical characterization of tremor in patients with Phenylketonuria (PKU)

    F. Nardecchia, F. Manti, S. De Leo, C. Carducci, V. Leuzzi (Rome, Italy)

    Objective: To assess the occurrence, age at onset, distribution, associated neurological signs and possible pathogenetic biomarkers of tremor in PKU. Background: PKU is an inborn…
  • 2018 International Congress

    No deleterious effect of unilateral Gamma Knife thalamotomy on gait and posture in patients with essential tremor

    T. Witjas, E. Boutin, A. Eusebio, R. Carron, J. Régis, JP. Azulay, M. Vaugoyeau (Marseille, France)

    Objective: We aimed to describe specific features of gait disorders and postural instability in patients with severe essential tremor (ET), and to evaluate the effect…
  • 2018 International Congress

    Pallidotomy in dystonia –Experience from a tertiary care centre in a developing country

    K. Garg, M. Singh, V. Goyal, R. Sharma (New Delhi, India)

    Objective: The objective of the present study was to determine the outcomes of pallidotomy in dystonia patients in a developing nation. Background: Pallidotomy is one…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley